As tech stacks grow larger and release updates more frequent, the old way of performing computer system validation (CSV) is becoming inefficient, and legacy models will soon fail to keep pace, leading to bad data, unaddressed risks, and significant material consequences.

Meanwhile, emerging realities and imperatives – like big data, AI, and the shift to computer software assurance (CSA) – create new questions that must be answered.

In our latest white-paper, three industry experts sit down to discuss how life sciences companies will need to adapt to survive and thrive in an era of unprecedented connectivity.

Find out the three things your life sciences company should be doing now to prepare for our industry’s future.